Anzeige
Mehr »
Login
Montag, 14.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Größtes Gold-Investment 2024? NexGold Mining - Fusion könnte der Katalysator sein, den Anleger brauchen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
761 Leser
Artikel bewerten:
(2)

OTAQ Plc: SIP Purchase, PDMR Shareholding & TVR

DJ SIP Purchase, PDMR Shareholding & TVR

OTAQ Plc (OTAQ) SIP Purchase, PDMR Shareholding & TVR 17-Feb-2023 / 14:33 GMT/BST Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

OTAQ plc

("OTAQ", or the "Company")

Share Incentive Plan Purchase

Director/PDMR Shareholding

Total Voting Rights

OTAQ, the innovative technology company targeting the aquaculture, geotracking and offshore markets, received notification on 17 February 2023 from Cytec Solutions Corporate Trustees Limited (the "SIP Trustee") in relation to the issue and allotment of 28,463 ordinary shares of 1 penny each in the Company ("Ordinary Shares") for the benefit of participants of the OTAQ Share Incentive Plan (the "SIP"), including a Person Discharging Managerial Responsibilities in the Company ("PDMR") outlined below in accordance with the rules of the SIP (the "SIP Award").

The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which each participating employee will acquire Ordinary Shares at the prevailing market price per share using contributions deducted from pre-tax salary in each calendar month ("Partnership Shares"), with each participating employee being awarded one Ordinary Share for each Partnership Share ("Matching Shares"), using newly issued shares.

Details of the number of Partnership Shares purchased by the PDMR at a price of 6.5 pence per Ordinary Share, and the number of Matching Shares allocated by the SIP Trustee to the PDMR for no consideration, is set out against their name in the table below.

Number of     Number of    Total beneficial holding  Percentage beneficial holding 
Name     Title     Partnership    Matching Shares following Admission    following Admission 
               Shares 
       Chief 
Philip Newby* Executive   2,307       2,307      1,397,730         1.09% 
       Officer 
       Chief 
Harald Rotsch Technology   2,308       2,308      2,400,826         1.88% 
       Officer 

*Philip Newby's beneficial holding includes 349,606 Ordinary Shares held by his wife, Diane Newby

The SIP Award has been satisfied by the issue of 28,463 new Ordinary Shares (the "SIP Shares") to the SIP Trustee. The SIP Shares shall rank pari passu in all respects with the Company's existing ordinary shares in issue. Application has been made to the Aquis Stock Exchange for the SIP Shares to be admitted to trading on the Access Segment of the AQSE Growth Market ("Admission"). It is expected that Admission will become effective on or around 8.00 am on 22 February 2023.

Total Voting Rights

Following Admission, the Company will have 127,885,513 Ordinary Shares in issue, with voting rights. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights will be 127,885,513.

This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

OTAQ PLC                        +44 (0) 1524 748028 
Adam Reynolds, Non-Executive Chairman 
Phil Newby, Chief Executive Officer 
 
Matt Enright, Chief Financial Officer 
 
Dowgate Capital Limited (AQSE Corporate Adviser & Broker) +44 (0)20 3903 7715 
David Poutney / James Serjeant 
 
Nicholas Chambers / Russell Cook 
 
Walbrook PR Limited (PR)                +44 (0)20 7933 8780 or OTAQ@walbrookpr.com 
Tom Cooper / Nick Rome                  0797 122 1972 or 07748 325 236 
 

About OTAQ

OTAQ is a highly innovative technology company targeting the aquaculture, geotracking and offshore markets. It already has a number of established products in its portfolio and is focused on further developing its presence, customer base and cross selling opportunities within core markets both organically and via acquisition.

OTAQ's aquaculture products, which include a sonar device (developed for Minnowtech LLC) to scan shrimp in ponds and water quality monitoring, are focused on maximising welfare and production yields. Additionally, the Company is developing a potentially game changing live plankton analysis product for finfish and shellfish farmers. It also continues to target opportunities in the acoustic deterrent devices market via its Sealfence product, which is used by salmon farmers, with global opportunities in Chile, Australia, Canada and Norway.

The Company is also developing high accuracy location trackers for specialist applications. Having already added clients within safety and multiple participant sport/racing applications, the Company is investigating wider market potential - including opportunities in the seafood industry.

OTAQ's offshore product range includes OceanSense subsea leak detection, Eagle IP camera systems, Lander seabed survey devices and Subsea electrical connectors and penetrators. It is targeting a number of growth opportunities in new territories and has a strong client base including Expro, Amphenol and National Oilwell Varco. The Company is also focused on the development of new products through this division, with the aim of increased cross-deployment of skills and technologies into the aquaculture arena.

The Company makes this announcement, including the notification(s) below, in accordance with the requirements of the EU Market Abuse Regulation.

1       Details of the person discharging managerial responsibilities / person closely associated 
 
       Name 
a)                         Philip Newby 
 
2       Reason for the notification 
 
a)      Position/status           Chief Executive Officer and PDMR 
 
b)      Initial notification /Amendment 
                          Initial Notification 
 
3       Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction 
       monitor 
 
 
a)      Name 
                          OTAQ plc 
 
b)      LEI 
                          213800CZGMYB5XTUXJ52 
 
4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 
       Description of the financial     Ordinary shares of 1 penny each 
       instrument, type of instrument 
 
a) 
 
       Identification code 
                          ISIN: GB00BK6JQ137 
 
 
       Nature of the transaction 
b)                         Purchase and allocation of Partnership and Matching Shares (no 
                          consideration), respectively, under the OTAQ SIP. 
 
 
 
                          Price(s) 
                                 Volume(s) 
c)      Price(s) and volume(s) 
                          6.5p+Nil   2,307 + 2,307 
 
                          Price(s) 
       Aggregated information             Aggregated volume (s) 
d) 
 
                               4,614 
                        3.25p 
 

e) Date of the transaction

17 February 2023

f) Place of the transaction

Aquis Stock Exchange (AQSE)

1       Details of the person discharging managerial responsibilities / person closely associated 
 
       Name 
a)                         Harald Rotsch 
 
2       Reason for the notification 
 
a)      Position/status           Chief Technology Officer and PDMR 
 
b)      Initial notification /Amendment 
                          Initial Notification 
 
3       Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction 
       monitor 
 
 
a)      Name 
                          OTAQ plc 
 
b)      LEI 
                          213800CZGMYB5XTUXJ52 
 
4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 
       Description of the financial     Ordinary shares of 1 penny each 
       instrument, type of instrument 
 
a) 
 
       Identification code 
                          ISIN: GB00BK6JQ137 
 
 
       Nature of the transaction 
b)                         Purchase and allocation of Partnership and Matching Shares (no 
                          consideration), respectively, under the OTAQ SIP. 
 
 
 
                          Price(s) 
                                 Volume(s) 
c)      Price(s) and volume(s) 
                          6.5p+Nil   2,308 + 2,308 
 
                          Price(s) 
       Aggregated information             Aggregated volume (s) 
d) 
 
                               4,616 
                        3.25p 
 

e) Date of the transaction

17 February 2023

f) Place of the transaction

Aquis Stock Exchange (AQSE)

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00BK6JQ137 
Category Code: DSH 
TIDM:      OTAQ 
LEI Code:    213800CZGMYB5XTUXJ52 
OAM Categories: 2.5. Total number of voting rights and capital 
Sequence No.:  224168 
EQS News ID:  1563163 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1563163&application_name=news

(END) Dow Jones Newswires

February 17, 2023 09:34 ET (14:34 GMT)

© 2023 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.